We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+9.44%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$41.4B
AUM Growth
+$1.28B
Cap. Flow
-$1.91B
Cap. Flow %
-4.63%
Top 10 Hldgs %
19.95%
Holding
963
New
43
Increased
270
Reduced
584
Closed
33

Top Sells

1
TS icon
Tenaris
TS
+$173M
2
BKNG icon
Booking.com
BKNG
+$165M
3
CE icon
Celanese
CE
+$145M
4
MCD icon
McDonald's
MCD
+$123M
5
MSFT icon
Microsoft
MSFT
+$103M

Sector Composition

1 Technology 17.37%
2 Financials 14.73%
3 Consumer Discretionary 11.57%
4 Healthcare 11.23%
5 Communication Services 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTN
101
DELISTED
Raytheon Company
RTN
$77.3M 0.19%
351,674
-77,296
-18% -$16.3M
HDB icon
102
HDFC Bank
HDB
$135B
$77.1M 0.19%
2,433,096
-386,650
-14% -$11.8M
GMED icon
103
Globus Medical
GMED
$11B
$76.9M 0.19%
1,306,138
-3,499
-0.3% -$190K
IBM icon
104
IBM
IBM
$206B
$75.9M 0.18%
591,938
-24,260
-4% -$3.15M
LMT icon
105
Lockheed Martin
LMT
$118B
$73M 0.18%
187,424
+9,565
+5% +$3.67M
BA icon
106
Boeing
BA
$169B
$72.9M 0.18%
223,753
-263,043
-54% -$93.1M
TXN icon
107
Texas Instruments
TXN
$265B
$72.7M 0.18%
566,790
-191,007
-25% -$23.6M
AMGN icon
108
Amgen
AMGN
$201B
$70.7M 0.17%
293,319
-8,408
-3% -$1.85M
TGT icon
109
Target
TGT
$63.7B
$69M 0.17%
538,264
+2,625
+0.5% +$308K
NKE icon
110
Nike
NKE
$66.1B
$68.9M 0.17%
679,763
-9,006
-1% -$849K
HZNP
111
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$66.6M 0.16%
1,839,718
+346,321
+23% +$10.6M
NSC icon
112
Norfolk Southern
NSC
$75.9B
$66.4M 0.16%
342,226
+43,254
+14% +$8.11M
ORCL icon
113
Oracle
ORCL
$358B
$65.5M 0.16%
1,236,553
-57,002
-4% -$3.14M
ABT icon
114
Abbott
ABT
$172B
$64.6M 0.16%
743,384
-19,496
-3% -$1.63M
SCI icon
115
Service Corp International
SCI
$11B
$63.5M 0.15%
1,379,859
-1,201,846
-47% -$54.2M
DLR icon
116
Digital Realty Trust
DLR
$64.2B
$63.3M 0.15%
528,401
-7,749
-1% -$954K
AVB icon
117
AvalonBay Communities
AVB
$27.8B
$62.9M 0.15%
299,994
-2,849
-0.9% -$610K
RBA icon
118
RB Global
RBA
$21.1B
$61.7M 0.15%
1,435,721
+189,400
+15% +$7.89M
ARE icon
119
Alexandria Real Estate Equities
ARE
$8.74B
$61.1M 0.15%
378,116
-8,148
-2% -$1.28M
MRO
120
DELISTED
Marathon Oil Corporation
MRO
$61M 0.15%
4,490,411
+23,629
+0.5% +$288K
O icon
121
Realty Income
O
$61.3B
$60.9M 0.15%
853,971
+4,983
+0.6% +$371K
PODD icon
122
Insulet
PODD
$11.4B
$60.9M 0.15%
355,812
+5,742
+2% +$957K
CVS icon
123
CVS Health
CVS
$136B
$60.7M 0.15%
817,679
-49,146
-6% -$3.45M
LOW icon
124
Lowe's Companies
LOW
$121B
$60.3M 0.15%
503,628
-18,779
-4% -$2.15M
ELS icon
125
Equity Lifestyle Properties
ELS
$12.8B
$60M 0.14%
851,993
+8,487
+1% +$590K

Similar funds

Aberdeen Group's Q4 2019 Portfolio in Review

As of Q4 2019, Aberdeen Group held 963 positions worth $41.4B, up 3.2% from $40.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aberdeen Group withdrew a net $1.91B in Q4 2019, closing 33 positions and reducing 584 holdings. Its most notable exit was Celgene Corp, an estimated $31.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Aberdeen Group opened a new position in Allison Transmission worth $182M.

  • Aberdeen Group's largest Q4 2019 buy was Allison Transmission: 3,774,953 shares worth $182M.
  • Aberdeen Group added most to United Parcel Service in Q4 2019, an estimated $213M increase.
  • Aberdeen Group's biggest Q4 2019 reduction was Tenaris, cutting an estimated $173M.
  • Aberdeen Group fully exited Celgene Corp in Q4 2019, selling an estimated $31.4M.
  • Aberdeen Group's ten largest holdings make up 20% of its $41.4B portfolio in Q4 2019.
  • Aberdeen Group opened 43 new positions and closed 33 in Q4 2019.
  • Aberdeen Group's portfolio value rose 3.2% quarter-over-quarter to $41.4B.

Based on Aberdeen Group's 13F filing for Q4 2019, filed 18 Feb 2020.